These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways. Rose AC; Goddard CA; Colledge WH; Cheng SH; Gill DR; Hyde SC Gene Ther; 2002 Oct; 9(19):1312-20. PubMed ID: 12224014 [TBL] [Abstract][Full Text] [Related]
16. Cationic lipid:pDNA complexes for the treatment of cystic fibrosis. Eastman SJ; Scheule RK Curr Opin Mol Ther; 1999 Apr; 1(2):186-96. PubMed ID: 11715942 [TBL] [Abstract][Full Text] [Related]
17. A murine tracheal culture system to investigate parameters affecting gene therapy for cystic fibrosis. Scott ES; Goddard CA; Wiseman JW; Evans MJ; Colledge WH Gene Ther; 2000 Apr; 7(7):612-8. PubMed ID: 10819577 [TBL] [Abstract][Full Text] [Related]
18. [Prospects of gene therapy in mucoviscidosis using viral infection of the airway epithelium]. Bayle JY; Boucher RC Rev Mal Respir; 1994; 11(4):345-55. PubMed ID: 7526426 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy for cystic fibrosis lung disease: current status and future perspectives. Rosenecker J; Huth S; Rudolph C Curr Opin Mol Ther; 2006 Oct; 8(5):439-45. PubMed ID: 17078386 [TBL] [Abstract][Full Text] [Related]
20. Ability of a chimeric cAMP-responsive promoter to confer pharmacologic control of CFTR cDNA expression and cAMP-mediated Cl- secretion. Suzuki M; Singh RN; Crystal RG Gene Ther; 1997 Nov; 4(11):1195-201. PubMed ID: 9425443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]